Ceesay Abraham

Chief Executive Officer, DirectorRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Sep 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.0M
Net Open-Market Flow
-$2.0M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 17, 2025Sell(S)39K$26.30$1.0M587K
Sep 17, 2025Sell(S)1K$26.87$38K585K
Sep 17, 2025Sell(S)35K$26.30$917K47K
Sep 17, 2025Sell(S)700$27.04$19K46K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-209062) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about RAPP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-25-209062"
Ask your agent
Use Arkolith to summarize insider buying and selling at Rapport Therapeutics, Inc.
over the last 90 days and cite the filings.